Bethesda, Md. – Mary Beth Bassett, BS, MT(ASCP), was installed as president of AABB (formerly known as the American Association of Blood Banks) for the 2017-2018 term at the Association’s 2017 Annual Meeting in San Diego. Bassett succeeds Zbigniew M. Szczepiorkowski, MD, PhD, FCAP, as president.
Bassett has served as a member of the AABB Board of Directors since 2008. In that capacity, she chaired the Board’s Governance Committee, Bylaws Committee, HR Committee and served on Quality Management/Assurance, Regulatory Compliance, and Administration committees. In 2011, Bassett received AABB’s Hemphill Jordan Leadership Award in recognition of her dedication and outstanding leadership in the quality and compliance field.
“It is my honor and privilege to serve as president of AABB,” said Mary Beth Bassett, AABB’s new president. “Along with that honor comes a deep responsibility. I will work tirelessly to live up to the expectations of our members, to respect the legacy the of this organization and to embrace the accomplishments of those who have gone before me. Working together, we will fulfill AABB’s renewed Vision of making transfusion medicine and cellular therapies safe, available and effective worldwide.”
As the executive vice president and chief quality officer at Blood Systems, Bassett has been overseeing the development and execution of quality and regulatory programs for this transfusion medicine organization and its affiliates since 1996. She also leads the organization’s performance improvement program, Operational Excellence and its quality consulting service.
In the course of her career, Bassett has also served as the principal officer of the American Red Cross National Testing Laboratory in St. Louis, as well as director of the HLA/transplant laboratory and director of quality assurance of ARC’s Missouri-Illinois Blood Services Region. In her time with ARC, Bassett served as acting national director of quality assurance in Washington, DC. Previously, she was the president and chief executive officer for Gateway Community Blood Program in St. Louis.
Bassett received her Bachelor of Science degree in microbiology from South Dakota State University and a Bachelor of Science degree in medical technology from St. Joseph Mercy Hospital.
AABB members also elected Michael F. Murphy, MD, FRCP, FRCPath, FFPath, as the 2018-19 Association president; Dana Devine, PhD, as vice president; Dan Waxman, MD, as secretary of the AABB Board of Directors; P. Dayand Borge, Jr., MD, PhD as at-large director (position 1); and Melanie Champion, MBA, MT(ASCP)SBB, HP, as at-large director (position 5).
To view the complete list of the AABB Board of Directors, please visit: http://www.aabb.org/membership/governance/Pages/default.aspx
AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and cellular therapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries.